King Files 20 Levoxyl Patent Applications; Sales Up 65% to $27 Mil. In Q3
Executive Summary
King has filed 20 patent applications for Levoxyl (levothyroxine) to extend exclusivity for the thyroid hormone product, the company said during an Oct. 29 earnings call